Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2010

01.11.2010 | Review

Management of Large Hepatocellular Carcinoma in Adult Patients with Alagille Syndrome: A Case Report and Review of Literature

verfasst von: Susan Tsai, Ahmet Gurakar, Robert Anders, Dora Lam-Himlin, John Boitnott, Timothy M. Pawlik

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Alagille syndrome is a multi-system developmental disorder associated with paucity of interlobular bile ducts and cholestasis, rarely associated with hepatocellular carcinoma. Associated syndromic co-morbidities may complicate surgical management. As such, we herein review the modern management of a large hepatocellular carcinoma in an adult patient with Alagille syndrome and review the literature of adult Alagille patients with hepatocellular carcinoma.

Case Presentation

A 29-year-old woman with a history of Alagille syndrome was referred with biopsy-proven 12 × 8 cm hepatocellular carcinoma replacing her right liver. Biopsy of the contralateral liver demonstrated findings consistent with Alagille syndrome, but no underlying cirrhosis. CT volumetrics demonstrated a future liver remnant of 40%. Extensive hematologic and cardiac work-up was performed pre-operatively, given the syndrome’s associated bleeding dyscrasias and cardiac abnormalities. The patient underwent a margin-negative right hepatectomy using the “hanging” technique through a thoracoabdominal approach. The patient developed a transient hyperbilirubinemia but no hepatic insufficiency and did well post-operatively.

Conclusion

Since Alagille syndrome affects multiple organ systems, preoperative evaluation of cardiac, hematologic, and hepatic function should be considered. This case illustrates the peri-operative management of an Alagille patient, and highlights several key technical points that contributed to a successful resection.
Literatur
1.
Zurück zum Zitat Danks DM, Campbell PE, Jack I, Rogers J, Smith AL. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child. 1977;52(5):360–367.CrossRefPubMed Danks DM, Campbell PE, Jack I, Rogers J, Smith AL. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child. 1977;52(5):360–367.CrossRefPubMed
2.
Zurück zum Zitat Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997;16(3):235–242.CrossRefPubMed Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997;16(3):235–242.CrossRefPubMed
3.
Zurück zum Zitat Kamath BM, Bason L, Piccoli DA, Krantz ID, Spinner NB. Consequences of JAG1 mutations. J Med Genet. 2003;40(12):891–895.CrossRefPubMed Kamath BM, Bason L, Piccoli DA, Krantz ID, Spinner NB. Consequences of JAG1 mutations. J Med Genet. 2003;40(12):891–895.CrossRefPubMed
4.
Zurück zum Zitat LaBrecque DR, Mitros FA, Nathan RJ, Romanchuk KG, Judisch GF, El-Khoury GH. Four generations of arteriohepatic dysplasia. Hepatology. 1982;2(4):467–474. (Baltimore, Md).CrossRefPubMed LaBrecque DR, Mitros FA, Nathan RJ, Romanchuk KG, Judisch GF, El-Khoury GH. Four generations of arteriohepatic dysplasia. Hepatology. 1982;2(4):467–474. (Baltimore, Md).CrossRefPubMed
5.
Zurück zum Zitat Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999;29(3):822–829. (Baltimore, Md).CrossRefPubMed Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999;29(3):822–829. (Baltimore, Md).CrossRefPubMed
6.
Zurück zum Zitat Tzakis AG, Reyes J, Tepetes K, Tzoracoleftherakis V, Todo S, Starzl TE. Liver transplantation for Alagille’s syndrome. Arch Surg. 1993;128(3):337–339.PubMed Tzakis AG, Reyes J, Tepetes K, Tzoracoleftherakis V, Todo S, Starzl TE. Liver transplantation for Alagille’s syndrome. Arch Surg. 1993;128(3):337–339.PubMed
7.
Zurück zum Zitat Sugiyama H, Veldtman GR, Norgard G, Lee KJ, Chaturvedi R, Benson LN. Bladed balloon angioplasty for peripheral pulmonary artery stenosis. Catheter Cardiovasc Interv. 2004;62(1):71–77.CrossRefPubMed Sugiyama H, Veldtman GR, Norgard G, Lee KJ, Chaturvedi R, Benson LN. Bladed balloon angioplasty for peripheral pulmonary artery stenosis. Catheter Cardiovasc Interv. 2004;62(1):71–77.CrossRefPubMed
8.
Zurück zum Zitat Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351(14):1425–1436.CrossRefPubMed Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351(14):1425–1436.CrossRefPubMed
9.
Zurück zum Zitat Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001;193(1):109–111.CrossRefPubMed Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001;193(1):109–111.CrossRefPubMed
10.
Zurück zum Zitat Schwarzenberg SJ, Grothe RM, Sharp HL, Snover DC, Freese D. Long-term complications of arteriohepatic dysplasia. Am J Med. 1992;93(2):171–176.CrossRefPubMed Schwarzenberg SJ, Grothe RM, Sharp HL, Snover DC, Freese D. Long-term complications of arteriohepatic dysplasia. Am J Med. 1992;93(2):171–176.CrossRefPubMed
11.
Zurück zum Zitat Bekassy AN, Garwicz S, Wiebe T, Hagerstrand I, Jensen OA. Hepatocellular carcinoma associated with arteriohepatic dysplasia in a 4-year-old girl. Med Pediatr Oncol. 1992;20(1):78–83.CrossRefPubMed Bekassy AN, Garwicz S, Wiebe T, Hagerstrand I, Jensen OA. Hepatocellular carcinoma associated with arteriohepatic dysplasia in a 4-year-old girl. Med Pediatr Oncol. 1992;20(1):78–83.CrossRefPubMed
12.
Zurück zum Zitat Adams PC. Hepatocellular carcinoma associated with arteriohepatic dysplasia. Dig Dis Sci. 1986;31(4):438–442.CrossRefPubMed Adams PC. Hepatocellular carcinoma associated with arteriohepatic dysplasia. Dig Dis Sci. 1986;31(4):438–442.CrossRefPubMed
13.
Zurück zum Zitat Kim B, Park SH, Yang HR, Seo JK, Kim WS, Chi JG. Hepatocellular carcinoma occurring in alagille syndrome. Pathol Res Pract. 2005;201(1):55–60.CrossRefPubMed Kim B, Park SH, Yang HR, Seo JK, Kim WS, Chi JG. Hepatocellular carcinoma occurring in alagille syndrome. Pathol Res Pract. 2005;201(1):55–60.CrossRefPubMed
14.
Zurück zum Zitat Le Bail B, Bioulac-Sage P, Arnoux R, Perissat J, Saric J, Balabaud C. Late recurrence of a hepatocellular carcinoma in a patient with incomplete Alagille syndrome. Gastroenterology. 1990;99(5):1514–1516.PubMed Le Bail B, Bioulac-Sage P, Arnoux R, Perissat J, Saric J, Balabaud C. Late recurrence of a hepatocellular carcinoma in a patient with incomplete Alagille syndrome. Gastroenterology. 1990;99(5):1514–1516.PubMed
15.
Zurück zum Zitat Rabinovitz M, Imperial JC, Schade RR, Van Thiel DH. Hepatocellular carcinoma in Alagille’s syndrome: a family study. J Pediatr Gastroenterol Nutr. 1989;8(1):26–30.CrossRefPubMed Rabinovitz M, Imperial JC, Schade RR, Van Thiel DH. Hepatocellular carcinoma in Alagille’s syndrome: a family study. J Pediatr Gastroenterol Nutr. 1989;8(1):26–30.CrossRefPubMed
16.
Zurück zum Zitat duCret RP, Cefalu JB, Alford BA, Drake G, Boudreau RJ. Hepatocarcinoma in association with the Alagille syndrome. Clin Nucl Med. 1988;13(12):920–921.CrossRefPubMed duCret RP, Cefalu JB, Alford BA, Drake G, Boudreau RJ. Hepatocarcinoma in association with the Alagille syndrome. Clin Nucl Med. 1988;13(12):920–921.CrossRefPubMed
17.
Zurück zum Zitat Keeffe EB, Pinson CW, Ragsdale J, Zonana J. Hepatocellular carcinoma in arteriohepatic dysplasia. Am J Gastroenterol. 1993;88(9):1446–1449.PubMed Keeffe EB, Pinson CW, Ragsdale J, Zonana J. Hepatocellular carcinoma in arteriohepatic dysplasia. Am J Gastroenterol. 1993;88(9):1446–1449.PubMed
18.
Zurück zum Zitat Ong E, Williams SM, Anderson JC, Kaplan PA. MR imaging of a hepatoma associated with Alagille syndrome. J Comput Assist Tomogr. 1998;10(6):1047–1049.CrossRef Ong E, Williams SM, Anderson JC, Kaplan PA. MR imaging of a hepatoma associated with Alagille syndrome. J Comput Assist Tomogr. 1998;10(6):1047–1049.CrossRef
19.
Zurück zum Zitat Wegmann W, Evison J, Schaub N, Kist L, Vest M. Liver cell carcinoma as a late complication of Alagille syndrome (arterio-hepatic dysplasia). Leber, Magen, Darm. 1996; 26(3):157–158, 61–63. Wegmann W, Evison J, Schaub N, Kist L, Vest M. Liver cell carcinoma as a late complication of Alagille syndrome (arterio-hepatic dysplasia). Leber, Magen, Darm. 1996; 26(3):157–158, 61–63.
20.
Zurück zum Zitat Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88(2):165–175.CrossRefPubMed Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88(2):165–175.CrossRefPubMed
21.
Zurück zum Zitat Tracy TF Jr, Bailey PV, Goerke ME, Sotelo-Avila C, Weber TR. Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. Surgery. 1991;110(2):176–182. Discussion 82–83.PubMed Tracy TF Jr, Bailey PV, Goerke ME, Sotelo-Avila C, Weber TR. Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. Surgery. 1991;110(2):176–182. Discussion 82–83.PubMed
22.
Zurück zum Zitat Nakano K, Chijiiwa K, Tanaka M. Lower activity of CCAAT/enhancer-binding protein and expression of cyclin E, but not cyclin D1, activating protein-1 and p21(WAF1), after partial hepatectomy in obstructive jaundice. Biochem Biophys Res Commun. 2001;280(3):640–645.CrossRefPubMed Nakano K, Chijiiwa K, Tanaka M. Lower activity of CCAAT/enhancer-binding protein and expression of cyclin E, but not cyclin D1, activating protein-1 and p21(WAF1), after partial hepatectomy in obstructive jaundice. Biochem Biophys Res Commun. 2001;280(3):640–645.CrossRefPubMed
23.
Zurück zum Zitat Wang DS, Dou KF, Li KZ, Gao ZQ, Song ZS, Liu ZC. Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats. World J Gastroenterol. 2003;9(12):2737–2741.PubMed Wang DS, Dou KF, Li KZ, Gao ZQ, Song ZS, Liu ZC. Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats. World J Gastroenterol. 2003;9(12):2737–2741.PubMed
24.
Zurück zum Zitat Png K, Veyckemans F, De Kock M, et al. Hemodynamic changes in patients with Alagille’s syndrome during orthotopic liver transplantation. Anesth Analg. 1999;89(5):1137–1142.CrossRefPubMed Png K, Veyckemans F, De Kock M, et al. Hemodynamic changes in patients with Alagille’s syndrome during orthotopic liver transplantation. Anesth Analg. 1999;89(5):1137–1142.CrossRefPubMed
25.
Zurück zum Zitat Ovaert C, Germeau C, Barrea C, et al. Elevated right ventricular pressures are not a contraindication to liver transplantation in Alagille syndrome. Transplantation. 2001;72(2):345–347.CrossRefPubMed Ovaert C, Germeau C, Barrea C, et al. Elevated right ventricular pressures are not a contraindication to liver transplantation in Alagille syndrome. Transplantation. 2001;72(2):345–347.CrossRefPubMed
26.
Zurück zum Zitat Nanashima A, Sumida Y, Abo T, Nagayasu T, Sawai T. Usefulness and application of the liver hanging maneuver for anatomical liver resections. World J Surg. 2008;32(9):2070–2076.CrossRefPubMed Nanashima A, Sumida Y, Abo T, Nagayasu T, Sawai T. Usefulness and application of the liver hanging maneuver for anatomical liver resections. World J Surg. 2008;32(9):2070–2076.CrossRefPubMed
Metadaten
Titel
Management of Large Hepatocellular Carcinoma in Adult Patients with Alagille Syndrome: A Case Report and Review of Literature
verfasst von
Susan Tsai
Ahmet Gurakar
Robert Anders
Dora Lam-Himlin
John Boitnott
Timothy M. Pawlik
Publikationsdatum
01.11.2010
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2010
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-1123-7

Weitere Artikel der Ausgabe 11/2010

Digestive Diseases and Sciences 11/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.